These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8352892)

  • 1. Protein synthesis-dependent cytoplasmic translocation of p53 protein after serum stimulation of growth-arrested MCF-7 cells.
    Takahashi K; Sumimoto H; Suzuki K; Ono T
    Mol Carcinog; 1993; 8(1):58-66. PubMed ID: 8352892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA synthesis by TGF-beta 1 coincides with inhibition of phosphorylation and cytoplasmic translocation of p53 protein.
    Suzuki K; Ono T; Takahashi K
    Biochem Biophys Res Commun; 1992 Mar; 183(3):1175-83. PubMed ID: 1567396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of insulin-like growth-factor-I-induced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF-7 cells.
    Takahashi K; Suzuki K
    Int J Cancer; 1993 Sep; 55(3):453-8. PubMed ID: 8375929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1.
    Borellini F; Glazer RI
    J Biol Chem; 1993 Apr; 268(11):7923-8. PubMed ID: 8463313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport.
    Gannon JV; Lane DP
    Nature; 1991 Feb; 349(6312):802-6. PubMed ID: 2000149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-associated 3'-->5' exonuclease activity in nuclear and cytoplasmic compartments of cells.
    Lilling G; Elena N; Sidi Y; Bakhanashvili M
    Oncogene; 2003 Jan; 22(2):233-45. PubMed ID: 12527892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of DNA binding and transcriptional regulatory function of an endogenous mutant p53 in MDA-468 human breast cancer cells.
    Prasad KA; Church JG
    Biochem Biophys Res Commun; 1997 Mar; 232(1):14-9. PubMed ID: 9125118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA synthesis-associated nuclear exclusion of p53 in normal human breast epithelial cells in culture.
    Takahashi K; Suzuki K
    Oncogene; 1994 Jan; 9(1):183-8. PubMed ID: 8302577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion.
    Knippschild U; Oren M; Deppert W
    Oncogene; 1996 Apr; 12(8):1755-65. PubMed ID: 8622896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple p53 protein isoforms and formation of oligomeric complexes with heat shock proteins Hsp70 and Hsp90 in the human mammary tumor, T47D, cell line.
    Selkirk JK; Merrick BA; Stackhouse BL; He C
    Appl Theor Electrophor; 1994; 4(1):11-8. PubMed ID: 7811761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transforming p53 mutant, which binds DNA, transactivates and induces apoptosis reveals a nuclear:cytoplasmic shuttling defect.
    Crook T; Parker GA; Rozycka M; Crossland S; Allday MJ
    Oncogene; 1998 Mar; 16(11):1429-41. PubMed ID: 9525742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPA-induced differentiation of human rhabdomyosarcoma cells involves dephosphorylation and nuclear accumulation of mutant P53.
    Germani A; Fusco C; Martinotti S; Musarò A; Molinaro M; Zani BM
    Biochem Biophys Res Commun; 1994 Jul; 202(1):17-24. PubMed ID: 8037710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
    Moll UM; Riou G; Levine AJ
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7262-6. PubMed ID: 1353891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
    Huang Y; Tan M; Gosink M; Wang KK; Sun Y
    Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization.
    Goldman SC; Chen CY; Lansing TJ; Gilmer TM; Kastan MB
    Am J Pathol; 1996 May; 148(5):1381-5. PubMed ID: 8623910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.
    Tembe V; Martino-Echarri E; Marzec KA; Mok MT; Brodie KM; Mills K; Lei Y; DeFazio A; Rizos H; Kettle E; Boadle R; Henderson BR
    Cell Signal; 2015 Sep; 27(9):1763-71. PubMed ID: 26022179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: cross-talk with p53 signaling pathway.
    Lee YN; Park YG; Choi YH; Cho YS; Cho-Chung YS
    Biochemistry; 2000 Apr; 39(16):4863-8. PubMed ID: 10769144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells.
    Kim DH; Kim EH; Na HK; Surh YJ
    Ann N Y Acad Sci; 2009 Aug; 1171():202-9. PubMed ID: 19723057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific DNA-binding properties of oncoprotein p53 in human tumor cells].
    Zaĭchuk TA; Kuznetsov NV; Osovskaia VS; Kopnin BP; Chumakov PM
    Dokl Akad Nauk; 1993 May; 330(3):379-82. PubMed ID: 8334418
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide.
    Ostermeyer AG; Runko E; Winkfield B; Ahn B; Moll UM
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15190-4. PubMed ID: 8986786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.